The αββα metallo β-lactamase (MBL) fold (MBLf) was first observed in bacterial enzymes that catalyze the hydrolysis of almost all β-lactam antibiotics, but is now known to be widely distributed. The MBL core protein fold is present in human enzymes with diverse biological roles, including cell detoxification pathways and enabling resistance to clinically important anticancer medicines. Human (h)MBLf enzymes can bind metals, including zinc and iron ions, and catalyze a range of chemically interesting reactions, including both redox (e.g., ETHE1) and hydrolytic processes (e.g., Glyoxalase II, SNM1 nucleases, and CPSF73). With a view to promoting basic research on MBLf enzymes and their medicinal targeting, here we summarize current knowledge ...
β-Lactamase production increasingly threatens the effectiveness of β-lactams, which remain a mainsta...
Metallo--lactamases (MBLs) catalyse the hydrolysis of almost all -lactam antibacterials including th...
The discovery of penicillin and its subsequent development for clinical use against bacterial infect...
The αββα metallo β-lactamase (MBL) fold (MBLf) was first observed in bacterial enzymes that catalyze...
The αββα metallo β-lactamase (MBL) fold (MBLf) was first observed in bacterial enzymes that catalyze...
The metallo-β-lactamase (MBL) superfamily is characterised by a unique αββα structural fold and is w...
The ability to produce ß-lactamase enzymes is the major cause of the resistance of bacteria to ß-lac...
International audienceβ-lactamase enzymes have generated significant interest due to their ability t...
Metallo-β-lactamases (Ambler’s class B, Bush-Jacoby’s classification group 3) are zinc-dependent enz...
The spread of antibiotic resistance is one major global problem for healthcare systems. One of the m...
Metallo-b-lactamases (MBLs) are zinc-dependent hydrolases that inactivate virtually all b-lactam ant...
The emergence of multidrug-resistant (MDR) Gram-negative pathogens and lack of new antibiotics in th...
Metallo-β-lactamases (MBLs) are powerful enzymes capable of conferring pathogenic bacteria with effe...
AbstractMetallo-β-lactamases (MBLs) catalyse the hydrolysis of almost all β-lactam antibacterials in...
Metallo-beta-lactamases (MBLs) are a family of Zn(II)-dependent enzymes that inactivate most of the ...
β-Lactamase production increasingly threatens the effectiveness of β-lactams, which remain a mainsta...
Metallo--lactamases (MBLs) catalyse the hydrolysis of almost all -lactam antibacterials including th...
The discovery of penicillin and its subsequent development for clinical use against bacterial infect...
The αββα metallo β-lactamase (MBL) fold (MBLf) was first observed in bacterial enzymes that catalyze...
The αββα metallo β-lactamase (MBL) fold (MBLf) was first observed in bacterial enzymes that catalyze...
The metallo-β-lactamase (MBL) superfamily is characterised by a unique αββα structural fold and is w...
The ability to produce ß-lactamase enzymes is the major cause of the resistance of bacteria to ß-lac...
International audienceβ-lactamase enzymes have generated significant interest due to their ability t...
Metallo-β-lactamases (Ambler’s class B, Bush-Jacoby’s classification group 3) are zinc-dependent enz...
The spread of antibiotic resistance is one major global problem for healthcare systems. One of the m...
Metallo-b-lactamases (MBLs) are zinc-dependent hydrolases that inactivate virtually all b-lactam ant...
The emergence of multidrug-resistant (MDR) Gram-negative pathogens and lack of new antibiotics in th...
Metallo-β-lactamases (MBLs) are powerful enzymes capable of conferring pathogenic bacteria with effe...
AbstractMetallo-β-lactamases (MBLs) catalyse the hydrolysis of almost all β-lactam antibacterials in...
Metallo-beta-lactamases (MBLs) are a family of Zn(II)-dependent enzymes that inactivate most of the ...
β-Lactamase production increasingly threatens the effectiveness of β-lactams, which remain a mainsta...
Metallo--lactamases (MBLs) catalyse the hydrolysis of almost all -lactam antibacterials including th...
The discovery of penicillin and its subsequent development for clinical use against bacterial infect...